. 2014 Jan 15;46(1):48–54. doi: 10.4143/crt.2014.46.1.48
Copyright © 2014 by the Korean Cancer Association
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Fig. 2.
Overall survival (OS) according to KRAS mutation status.